| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |